Connection of the publication with planned research works.The article is a fragment of a research work financed by the Ministry of Health of Ukraine at the expense of the state budget and entitled: "Genetic variants and their potential connection with COVID-19 among the population of Ukraine" (state registration number 0121U107440).Introduction.With its emergence, the pandemic of the disease COVID-19, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused a significant increase in the number of hospitalizations and deaths, primarily due to pneumonia with multiorgan involvement [1,2,3,4]. More and more vaccines against COVID-19 and new treatments are being developed worldwide [5,6,7,8]. However, the number of patients with COVID-19 remains high, leading to a high death rate. Another challenge for the global healthcare system may be the emergence of new SARS-CoV-2 variants associated with the constant mutation of the virus [9,10]. So far, the World Health Organization has identified the following variants of SARS-CoV-2: alpha, beta, gamma, delta, epsilon, eta, iota, kappa, mu, zeta, and omicron, and is now closely monitoring all omicron sublines [11,12]. The global risk associated with new variants of SARS-CoV-2, in the context of the COVID-19 pandemic and the displacement of large numbers of people due to the full-scale war in Ukraine, is determined to be very high [13].Therefore, a retrospective analysis of the characteristics and prognostic signs of progression to a more severe/fatal course of the disease is essential and will lay the foundation for a better understanding of the principles of diagnostic and therapeutic tactics of COVID-19 with the emergence of new mutant strains of SARS-CoV-2.
The aim of the study.To characterize the clinical course of severe forms of COVID-19 and to determine prognostic markers of disease progression to death.Object and research methods. This was a retrospective study conducted based on the data of 552 patients with a diagnosis of "Acute respiratory disease COVID-19" confirmed by the PCR method, who had a severe/critical course and were treated at the Department of Reanimation and Intensive Care of the Municipal enterprise "Poltava Regional Clinical Infectious Disease Hospital of Poltava Regional Council" from April 2020 to September 2022. We analyzed demographic, epidemiological, clinical and laboratory characteristics and risk factors at the time of hospital admission. Information about concomitant diseases was obtained from available medical documentation and personally from each patient or their relatives.This study was approved by the Ethics and Bioethics Committee of the Municipal enterprise "Poltava Regional Clinical Infectious Disease Hospital of Poltava Regional Council". Before conducting any diagnostic procedures and prescribing treatment, we obtained written informed consent from each patient or their family members.The severity of the disease was classified as follows: asymptomatic or presymptomatic, mild, moderate, severe, and criti...